Order Cytocare® for Clinics

Cytocare® is a professional mesotherapy and skin-booster line formulated with non-crosslinked hyaluronic acid and Revitacare’s CT50 rejuvenating complex. Licensed clinics, med spas, and healthcare professionals can order Cytocare® for intradermal skin-quality protocols, including face, neck, and décolletage applications. The line is used in treatment-room workflows that require sterile single-use vials, predictable handling, and documentation-ready supply.

Cytocare® 532 is one of the best-known formulations in the range and is commonly selected for hydration-focused revitalization plans. Practices may also evaluate Cytocare 516, Cytocare 715, Cytocare 502, Cytocare 640, Cytocare Stretchcare, or Cytocare Haircare when building a broader portfolio. Specific formulation choice should follow manufacturer instructions, practitioner training, local professional standards, and the clinical indication being treated.

Cytocare® Price and Clinic Ordering

Clinic accounts can sign in to view current Cytocare 532 price information, live product presentations, and any volume or contract tiers available to qualified purchasers. Pricing may vary by formulation, order quantity, and account terms, so purchasing teams should match the displayed Cytocare® presentation to the protocol and inventory plan used in their practice.

MedWholesaleSupplies serves licensed clinics and healthcare professionals with brand-name medical products sourced through vetted distributors and verified supply channels. Account verification may be required before purchasing professional-use injectable products. This helps align ordering with clinic documentation, practitioner oversight, and appropriate storage and handling expectations.

For practices standardizing mesotherapy stock, it may be useful to keep Cytocare® grouped with other intradermal skin-quality products. The mesotherapy category can support broader assortment planning across injectable revitalization protocols, while the Cytocare brand collection helps teams locate related formulations in the same line.

What Cytocare® Is Used For in Professional Aesthetics

Cytocare® mesotherapy is used by trained medical personnel in skin-quality programs that focus on hydration, dermal suppleness, radiance, and surface texture. The product class is typically administered by micro-injections into superficial, mid, or deeper dermal planes according to the formulation and the manufacturer’s directions. In practice, clinicians incorporate it into non-surgical facial revitalization workflows rather than using it as a structural volumizing filler.

Common treatment areas include the face, neck, and décolletage. Clinics may use Cytocare® as a standalone hydration step or combine it with staged aesthetic plans, provided timing, tissue condition, and treatment sequencing are clinically appropriate. When used around other modalities, practitioners should account for injection depth, healing time, skin sensitivity, and the manufacturer’s instructions for each product involved.

The phrase Cytocare injection usually refers to professional intradermal administration of the solution, not self-use or retail cosmetic application. Technique may involve fine needles, micro-papular placement, linear intradermal threading, or device-assisted delivery when supported by training and local standards. For device-based workflows, practices can review compatible delivery planning alongside mesotherapy treatment principles and internal clinic protocols.

Cytocare® 532, 516, and Other Formulations

Cytocare® 532 is part of a Revitacare mesotherapy line built around non-crosslinked hyaluronic acid and a rejuvenating complex. The 532 version is often discussed in relation to advanced skin-quality needs, including fine surface lines, hydration support, and radiance-focused treatment planning. Cytocare 516 is generally considered within balanced hydration and revitalization portfolios, while other line extensions may be chosen for distinct clinic indications.

Practices searching for Cytocare 532 10x5ml, Cytocare 516, Cytocare 715, Cytocare 502, Cytocare 640, Cytocare Stretchcare, or Cytocare Haircare should choose the formulation displayed during ordering and verify it against their treatment protocol. Do not substitute one version for another without clinical review, because formulation selection can affect injection plan, target tissue, and expected handling.

Quick tip: Keep a formulation note in your purchasing workflow so reception, inventory, and injector teams use the same Cytocare® naming convention.

Composition and How the Product Works

Cytocare® contains non-crosslinked hyaluronic acid combined with the CT50 complex. Hyaluronic acid is a naturally occurring glycosaminoglycan that binds water in tissue and is widely used in aesthetic dermatology. In mesotherapy, non-crosslinked HA is selected for intradermal hydration support rather than deep structural lift.

The CT50 complex is the line’s rejuvenating component and is intended to support skin-quality protocols when injected by trained professionals. This does not replace clinical evaluation, contraindication screening, or individualized treatment planning. Practitioners should review the product insert for the exact composition, excipients, injection guidance, and any formulation-specific precautions.

No lidocaine should be assumed unless the displayed formulation or manufacturer insert specifies it. Clinics that use topical anesthetics or other comfort measures should ensure those products are appropriate for the planned procedure and patient profile. Documentation should reflect the exact product used, lot number, expiry, anatomical area, and technique.

Professional Administration and Treatment-Room Workflow

Cytocare® is intended for administration by licensed medical professionals trained in injectable aesthetic procedures. The preparation is used in dermal planes according to the product instructions and clinic protocol. It is not a home-use cosmetic, and it should not be administered by untrained staff or offered outside an appropriate clinical setting.

Single-use sterile vials support aseptic setup and clear treatment-room handling. Staff should inspect packaging before use, confirm the product name and expiry, and document the lot number according to clinic policy. Once opened, the vial should be handled according to the manufacturer’s instructions and discarded when required by sterile-use procedures.

Clinics may organize Cytocare® sessions around seasonal skin maintenance, pre-event planning, or staged rejuvenation pathways. When combining mesotherapy with peels, energy-based devices, threads, or other injectables, plan sequencing carefully. For additional procedural context, review mesotherapy injection workflows and integrate only the steps appropriate for your practice’s scope and training.

Storage, Handling, and US Logistics

Follow the manufacturer’s storage instructions for the Cytocare® formulation purchased. Keep sterile products in their original packaging until use, protect them from inappropriate temperature exposure, and rotate inventory by expiry date. Treatment rooms should maintain a clear separation between unopened stock, products staged for a procedure, and materials that must be discarded.

Orders are processed for professional clinic supply with reliable US logistics, including temperature-controlled handling when required and tracked US delivery. Clinics placing multi-item orders should coordinate receiving staff so packages are inspected, recorded, and stored promptly on arrival. Any product with compromised packaging, unclear labeling, or suspected temperature mishandling should be quarantined and reviewed before use.

Inventory teams often pair Cytocare® with related consumables such as fine needles, cannulas when clinically appropriate, antiseptic supplies, and post-procedure materials. Keep those items in a procedure checklist so staff can prepare rooms consistently and avoid last-minute substitutions. For broader assortment planning, the skin boosters category provides adjacent product classes used in hydration and skin-quality programs.

Safety, Screening, and Professional Precautions

All injectable aesthetic products require appropriate screening before treatment. Clinicians should review medical history, allergies, active skin infection, inflammatory skin conditions, prior aesthetic procedures, pregnancy or breastfeeding status when relevant, and any medication or condition that may affect bruising, healing, or infection risk. Treatment should be deferred when patient factors or local tissue findings make injection unsuitable.

Expected post-injection reactions may include temporary redness, swelling, tenderness, bruising, itching, or small papules at injection points. More serious complications, although less common, can include infection, persistent nodules, hypersensitivity reactions, vascular compromise, or tissue injury if technique or product placement is inappropriate. Patients should receive clinic-specific aftercare instructions and clear guidance on when to contact the treating clinician.

Practitioners should avoid using Cytocare® in ways that conflict with the manufacturer’s instructions or their own scope of practice. Do not inject into areas with active infection or compromised tissue. Maintain aseptic technique, use appropriate sharps disposal, and record any adverse event according to clinic policy and applicable reporting requirements.

How Long Results May Last

The duration of visible skin-quality changes after Cytocare® treatment varies by formulation, injection technique, treatment area, baseline skin condition, and the maintenance schedule selected by the clinician. Mesotherapy products are typically used in programs rather than one-time structural correction plans. Clinics should set expectations around hydration support, surface texture, and maintenance timing rather than promising a fixed duration.

Many practices schedule a series of sessions followed by maintenance visits, but the exact interval belongs in the clinical protocol and should reflect patient response. Documentation from each visit can help the injector decide whether to repeat the same formulation, adjust timing, or choose another skin booster class. For a deeper line-specific discussion, see Cytocare 532 treatment considerations.

Is Cytocare® FDA Approved?

Cytocare® is a professional aesthetic mesotherapy line from Revitacare. Regulatory status can differ by country, formulation, and intended use, so clinics should verify the rules that apply to their own medical practice before purchasing or administering the product. A product’s international use or manufacturer information should not be treated as a substitute for local professional compliance review.

For US-based clinics, this distinction matters because search results and supplier descriptions may combine information from different markets. Review the manufacturer’s documentation, your state-level practice rules, and any medical director requirements before adding Cytocare® to treatment menus. The buying decision should align product documentation with practitioner training, informed consent, and adverse-event procedures.

Comparable Products and Portfolio Planning

Cytocare® fits within the broader skin-booster and mesotherapy category, where clinics may stock HA-based, nucleotide-based, and polynucleotide products for different skin-quality strategies. A strong portfolio helps injectors match treatment plans to tissue quality, seasonal demand, and patient history while keeping purchasing organized.

When comparing Cytocare® with adjacent choices, consider active ingredient class, injection plane, treatment area, sterility, vial format, and documentation needs. Do not evaluate products only by price; handling, training, indication fit, and adverse-event planning matter for professional use. Clinics reviewing technique, positioning, and patient-selection language may find Cytocare anti-aging protocol context useful for internal education.

For category-level expansion, use skin booster articles to support staff education and mesotherapy supplies to browse professional-use products in the same procedural family. Keep final purchasing decisions tied to the manufacturer insert and the clinician responsible for treatment.

Ordering Checklist for Licensed Practices

• Confirm the exact Cytocare® formulation required for the protocol.
• Match quantity to scheduled cases, maintenance plans, and expiry rotation.
• Verify clinic account access before ordering professional-use injectable products.
• Record lot, expiry, and product name at receiving and at treatment.
• Store products according to the manufacturer’s instructions.
• Use aseptic setup, sterile handling, and appropriate sharps disposal.
• Align patient consent and aftercare instructions with clinic policy.
• Review substitute formulations clinically before approving any change.

Authoritative Sources

• Laboratoire Revitacare product information
• StatPearls mesotherapy overview
• Peer-reviewed review of hyaluronic acid in aesthetic dermatology

Ready to equip your team? Sign in to view Cytocare® presentations, review current account pricing, and place a clinic order through verified professional supply channels.

This content is for informational purposes only and is not a substitute for professional medical advice.